Patents by Inventor Nofit Borenstein

Nofit Borenstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating autoimmune diseases of the central nervous system (CNS) and neurodegenerative diseases
    Patent number: 8901074
    Abstract: An insulin degrading enzyme (IDE) inhibitor for use in the treatment of a disease selected from the group consisting of an autoimmune disease of the central nervous system and a neurodegenerative disease is disclosed.
    Type: Grant
    Filed: August 4, 2011
    Date of Patent: December 2, 2014
    Assignee: Ramot at Tel-Aviv University
    Inventors: Dan Frenkel, Hilit Levy, Nofit Borenstein, Dorit Farfara, Dorit Trudler
  • Peptides, pharmaceutical compositions comprising same and uses thereof
    Patent number: 8691760
    Abstract: Use of an isolated peptide comprising an amino acid sequence being no more than 25 amino acids in length, the amino acid sequence comprising at least one aspartate or a homolog thereof, the peptide having an Insulin-Degrading Enzyme (IDE) inhibitory activity, for the manufacture of a medicament identified for treating a disease selected from the group consisting of diabetes, obesity, hyperglycemia, retinal damage, renal failure, nerve damage, microvascular damage and varicella-zoster virus (VZV) infection is disclosed.
    Type: Grant
    Filed: February 2, 2010
    Date of Patent: April 8, 2014
    Assignee: Ramot at Tel-Aviv University
    Inventors: Dan Frenkel, Adi Kopelevich, Veronica Lifshitz, Tali Benromano, Nofit Borenstein
  • METHODS OF TREATING AUTOIMMUNE DISEASES OF THE CENTRAL NERVOUS SYSTEM (CNS) AND NEURODEGENERATIVE DISEASES
    Publication number: 20130130976
    Abstract: An insulin degrading enzyme (IDE) inhibitor for use in the treatment of a disease selected from the group consisting of an autoimmune disease of the central nervous system and a neurodegenerative disease is disclosed.
    Type: Application
    Filed: August 4, 2011
    Publication date: May 23, 2013
    Inventors: Dan Frenkel, Hilit Levy, Nofit Borenstein, Dorit Farfara, Dorit Trudler
  • PEPTIDES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME AND USES THEREOF
    Publication number: 20120028894
    Abstract: Use of an isolated peptide comprising an amino acid sequence being no more than 25 amino acids in length, the amino acid sequence comprising at least one aspartate or a homolog thereof, the peptide having an Insulin-Degrading Enzyme (IDE) inhibitory activity, for the manufacture of a medicament identified for treating a disease selected from the group consisting of diabetes, obesity, hyperglycemia, retinal damage, renal failure, nerve damage, microvascular damage and varicella-zoster virus (VZV) infection is disclosed.
    Type: Application
    Filed: February 2, 2010
    Publication date: February 2, 2012
    Applicant: Ramot at Tel-Aviv University Ltd.
    Inventors: Dan Frenkel, Adi Kopelevich, Veronica Lifshitz, Tali Benromano, Nofit Borenstein